secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERU INC. (VERU)
CIK:        0000863894
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001193125-23-107340
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veru sells ENTADFI assets to Blue Water Vaccines for $20M upfront + up to $80M milestones
--------------------------------------------------------------------------------

- Asset purchase closed April 19, 2023; buyer paid $6M at closing, owes $4M in FY2023 and $10M in FY2024.
- Potential milestone payments of $10M/$20M/$50M if annual net sales reach $100M/$200M/$500M.
- Buyer assumed 6% royalty on ENTADFI sales and up to $22.5M in milestone obligations from Camargo agreement.
- Veru sold substantially all ENTADFI assets, including IP, regulatory approvals, inventory, and contracts.
- Deal shifts Veru's focus away from ENTADFI; milestone payments uncertain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/863894/000119312523107340/0001193125-23-107340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/863894/000119312523107340/d473204d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-107340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer